References:
  1. Gaspar N, Hawkins DS, Dirksen U, et al. Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. J Clin Oncol . 2015;33(27):3036-3046. doi:10.1200/JCO.2014.59.5256
  2. Chakraborty D, Rangamani S, Kulothungan V, et al. Trends in incidence of Ewing sarcoma of bone in India - Evidence from the National Cancer Registry Programme (1982-2011). J Bone Oncol . 2018;12:49-53. Published 2018 May 17. doi:10.1016/j.jbo.2018.04.002
  3. Folpe AL, Goldblum JR, Rubin BP, et al. Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol . 2005;29(8):1025-1033.
  4. Zhang L, Xiong L, Wu LM, et al. The patterns of distant metastasis and prognostic factors in patients with primary metastatic Ewing sarcoma of the bone. J Bone Oncol . 2021;30:100385. Published 2021 Aug 2. doi:10.1016/j.jbo.2021.100385
  5. Kissane JM, Askin FB, Foulkes M, Stratton LB, Shirley SF. Ewing’s sarcoma of bone: clinicopathologic aspects of 303 cases from the Intergroup Ewing’s Sarcoma Study. Hum Pathol . 1983;14(9):773-779. doi:10.1016/s0046-8177(83)80300-1
  6. McManus AP, Gusterson BA, Pinkerton CR, Shipley JM. The molecular pathology of small round-cell tumours–relevance to diagnosis, prognosis, and classification. J Pathol . 1996;178(2):116-121. doi:10.1002/(SICI)1096-9896(199602)178:2<116::AID-PATH494>3.0.CO;2-H
  7. Leavey PJ, Mascarenhas L, Marina N, et al. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children’s Oncology Group.Pediatr Blood Cancer . 2008;51(3):334-338. doi:10.1002/pbc.21618
  8. Rammal H, Ghanem I, Torbey PH, Dagher F, Kharrat K. Multifocal Ewing sarcoma of the foot. J Pediatr Hematol Oncol . 2008;30(4):298-300. doi:10.1097/MPH.0b013e3181647c14
  9. Bernstein M, Kovar H, Paulussen M, et al. Ewing’s sarcoma family of tumors: current management. Oncologist . 2006;11(5):503-519. doi:10.1634/theoncologist.11-5-503
  10. Widhe B, Widhe T. Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am . 2000;82(5):667-674. doi:10.2106/00004623-200005000-00007
  11. Bell SW, Young PS, Mahendra A. Primary bone tumours of the talus: the Scottish Bone Tumour Registry experience. Foot Ankle Surg . 2012;18(4):277-282. doi:10.1016/j.fas.2012.04.007
  12. Yang P, Evans S, Bali N, et al. Malignant bone tumours of the foot. Ann R Coll Surg Engl . 2017;99(7):568-572. doi:10.1308/rcsann.2017.0114
  13. Desai SS, Jambhekar NA. Pathology of Ewing’s sarcoma/PNET: Current opinion and emerging concepts. Indian J Orthop . 2010;44(4):363-368. doi:10.4103/0019-5413.69304
  14. Falk S, Alpert M. The clinical and roentgen aspects of Ewing’s sarcoma. Am J Med Sci . 1965;250(5):492-508. doi:10.1097/00000441-196511000-00002
  15. Shirley SK, Askin FB, Gilula LA, et al. Ewing’s sarcoma in bones of the hands and feet: a clinicopathologic study and review of the literature. J Clin Oncol . 1985;3(5):686-697. doi:10.1200/JCO.1985.3.5.686
  16. Cohen J, Brown KA, Grice DS. Ewing’s tumor of the talus (astragalus) simulating aseptic necrosis. J Bone Joint Surg Am . 1953;35-A(4):1008-1012.
  17. Iwamoto Y. Diagnosis and treatment of Ewing’s sarcoma. Jpn J Clin Oncol . 2007;37(2):79-89. doi:10.1093/jjco/hyl142
  18. Schatz J, Soper J, McCormack S, Healy M, Deady L, Brown W. Imaging of tumors in the ankle and foot. Top Magn Reson Imaging . 2010;21(1):37-50. doi:10.1097/RMR.0b013e31820ef556
  19. Zapata CP, Cuglievan B, Zapata CM, et al. PET/CT versus bone marrow biopsy in the initial evaluation of bone marrow infiltration in various pediatric malignancies. Pediatr Blood Cancer . 2018;65(2):10.1002/pbc.26814. doi:10.1002/pbc.26814
  20. Lee AF, Hayes MM, Lebrun D, et al. FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma.Appl Immunohistochem Mol Morphol . 2011;19(3):233-238. doi:10.1097/PAI.0b013e3181fd6697
  21. Adkins CD, Kitaoka HB, Seidl RK, Pritchard DJ. Ewing’s sarcoma of the foot. Clin Orthop Relat Res . 1997;(343):173-182.
  22. Khan Z, Hussain S, Carter SR. Tumours of the foot and ankle. Foot (Edinb) . 2015;25(3):164-172. doi:10.1016/j.foot.2015.06.001
  23. Casadei R, Magnani M, Biagini R, Mercuri M. Prognostic factors in Ewing’s sarcoma of the foot. Clin Orthop Relat Res . 2004;(420):230-238. doi:10.1097/00003086-200403000-00033
  24. Friedman DN, Chastain K, Chou JF, et al. Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience. Pediatr Blood Cancer . 2017;64(11):10.1002/pbc.26562. doi:10.1002/pbc.26562